This potential use would be informal initially, as there is very little or no formal clinical guidance on the use of pharmacotherapy to maintain weight loss, but as clinical trials have shown that people who discontinue AOMs typically regain weight, it is highly likely that real world use of these agents will include use to maintain weight loss and therefore that lower cost semaglutide may be preferred
2023;644:123322 Behr J, Demedts M, Buhl R, Costabel U, Dekhuijzen RP, Jansen HM, et al
Glucagon receptor activation increases hepatic fat oxidation, making MASLD a high-conviction indication for the triple agonist mechanism
And if it doesnt provide the necessary outcome, then they cannot be paid for that medicine
Vers le haut de la page
How much tirzepatide is used for weight loss